We are studying the safety and effects of mitapivat in adults with erythrocyte membranopathies. This includes looking at hemoglobin levels and how it may help with symptoms.
Health conditions and diseases that the clinical trial is designed to study and treat.
Erythrocyte membranopathies are a group of rare disorders that affect the membrane of red blood cells, leading to issues such as hemolysis (destruction of red blood cells) and anemia. These conditions can cause symptoms like fatigue, weakness, and jaundice due to the reduced number of healthy red blood cells.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.